Skip to main content

Paclitaxel (International)

Note: In some countries, this medicine may only be approved for veterinary use.

In the US, Paclitaxel (paclitaxel systemic) is a member of the drug class mitotic inhibitors and is used to treat Breast Cancer, Breast Cancer - Adjuvant, Breast Cancer - Metastatic, Kaposi's Sarcoma, Nasopharyngeal Carcinoma, Non Small Cell Lung Cancer, Ovarian Cancer and Wilms' Tumor.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L01CD01

CAS registry number (Chemical Abstracts Service)

0033069-62-4

Chemical Formula

C47-H51-N-O14

Molecular Weight

854

Therapeutic Categories

Cytostatic agent

Microtubule inhibitor

Taxane

Chemical Name

(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-1,2a,3,4,4a,6,9,10,11,12,12a,12b-dodecahydro-4,6,9,11,12,12b-hexahydroxy-4a,8,13,13-tetramethyl-7,11-methano-5H-cyclodeca[3,4]benz[1,2-b]oxet-5-one 6,12b-diacetate, 12-benzoate, 9-ester with (2R,3S)-N-benzoyl-3-phenylisoserine (WHO )

Foreign Names

Generic Names

Brand Names

Glossary

TermDefinition
BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Search international drugs